Page last updated: 2024-08-23

staurosporine and Lymphoproliferative Disorders

staurosporine has been researched along with Lymphoproliferative Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Champain, K; Csermak, K; Fabbro, D; Fletcher, L; Ganeshaguru, K; Hart, S; Jones, D; Man, A; Mehta, A; Meyer, T; Prentice, HG; Virchis, A; Wickremasinghe, R; Wright, F; Yap, A	1
Cools, J	1
Curiel, DT; Curiel, TJ; Johanning, F; Kasono, K; Piché, A	1

Trials

1 trial(s) available for staurosporine and Lymphoproliferative Disorders

Article	Year
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C. The hematology journal : the official journal of the European Haematology Association, 2002, Volume: 3, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Female; Hematologic Neoplasms; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Middle Aged; Protein Kinase C; Staurosporine	2002

Article

Year

A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C.

The hematology journal : the official journal of the European Haematology Association, 2002, Volume: 3, Issue:3

Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Female; Hematologic Neoplasms; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Middle Aged; Protein Kinase C; Staurosporine

2002

Other Studies

2 other study(ies) available for staurosporine and Lymphoproliferative Disorders

Article	Year
The hypereosinophilic syndrome: idiopathic or not, that is the question. Haematologica, 2005, Volume: 90, Issue:5 Topics: Antineoplastic Agents; Benzamides; Chromosome Deletion; Chromosomes, Human, Pair 4; Chronic Disease; Clone Cells; Diagnosis, Differential; Drug Resistance, Neoplasm; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Lymphoproliferative Disorders; mRNA Cleavage and Polyadenylation Factors; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Piperazines; Point Mutation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Staurosporine; T-Lymphocyte Subsets	2005
Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody. Gene therapy, 1998, Volume: 5, Issue:9 Topics: Antibodies, Viral; Antigens, Viral; B-Lymphocytes; Cell Death; Cell Line, Transformed; Enzyme Inhibitors; Gene Expression; Genes, bcl-2; Genetic Engineering; Genetic Therapy; HeLa Cells; Herpesvirus 4, Human; Humans; Intracellular Fluid; Lymphocyte Activation; Lymphoproliferative Disorders; Microscopy, Fluorescence; Staurosporine; Viral Matrix Proteins	1998

Article

Year

The hypereosinophilic syndrome: idiopathic or not, that is the question.

Haematologica, 2005, Volume: 90, Issue:5

Topics: Antineoplastic Agents; Benzamides; Chromosome Deletion; Chromosomes, Human, Pair 4; Chronic Disease; Clone Cells; Diagnosis, Differential; Drug Resistance, Neoplasm; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Lymphoproliferative Disorders; mRNA Cleavage and Polyadenylation Factors; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Piperazines; Point Mutation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Staurosporine; T-Lymphocyte Subsets

2005

Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody.

Gene therapy, 1998, Volume: 5, Issue:9

Topics: Antibodies, Viral; Antigens, Viral; B-Lymphocytes; Cell Death; Cell Line, Transformed; Enzyme Inhibitors; Gene Expression; Genes, bcl-2; Genetic Engineering; Genetic Therapy; HeLa Cells; Herpesvirus 4, Human; Humans; Intracellular Fluid; Lymphocyte Activation; Lymphoproliferative Disorders; Microscopy, Fluorescence; Staurosporine; Viral Matrix Proteins

1998